Riluzole
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2199 publications
Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasis.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
AO Spine Clinical Practice Recommendations for Adjunctive Medical Therapies in Acute Traumatic Spinal Cord Injury: Contemporary Concepts.
Journal: Global spine journal
Published: February 17, 2026
Four decades of ALS care: a retrospective study of epidemiology, clinical course and changes in management.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: February 12, 2026
Riluzole use and reasons for non-use in people with amyotrophic lateral sclerosis in Aotearoa New Zealand.
Journal: The New Zealand medical journal
Published: January 29, 2026
Acute spinal cord injury: contemporary management and novel therapies.
Journal: Asian spine journal
Published: January 25, 2026
Unrevealing possible mechanism of Riluzole, Salsalate and Nimodipine in Alzheimer's disease: multi-target network pharmacological perspective.
Journal: Inflammopharmacology
Published: January 17, 2026
Regulation of Autophagy and Metabolism in Hepatocellular Carcinoma: Involvement of Wnt-β-Catenin Pathway.
Journal: Journal of cellular and molecular medicine
Published: January 11, 2026
Riluzole Restores Circuit and Behavioral Function Altered by Allele-Specific Expression-Mediated LINC02449-CPLX1 Dysregulation.
Journal: Schizophrenia bulletin
Published: January 06, 2026
Impact of corticosteroid administration on glioblastoma progression before and after adjuvant treatments: recent updates on contradictory findings and mechanistic interactions.
Journal: Frontiers in oncology
Published: December 24, 2025
C9orf72-derived dipeptide repeat proteins poly-PR disrupt membrane excitability and synaptic function in cortical neurons.
Journal: Neurobiology of disease
Published: December 15, 2025
Intranasal co-delivery of riluzole and berberine via chitosan-coated PLGA nanoparticles for synergistic neuroprotection in Alzheimer's disease: formulation, characterization, and pharmacokinetics analysis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 04, 2025
Amyotrophic lateral sclerosis in Saudi Arabia: a multicenter descriptive study.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: November 24, 2025
Last Updated: 04/28/2026